Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. At42617
2. 2296814-85-0
| Molecular Weight | 4167 g/mol |
|---|---|
| Molecular Formula | C192H302N46O57 |
| XLogP3 | -5 |
| Hydrogen Bond Donor Count | 57 |
| Hydrogen Bond Acceptor Count | 62 |
| Rotatable Bond Count | 148 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 1660 |
| Heavy Atom Count | 295 |
| Formal Charge | 0 |
| Complexity | 9920 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 40 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
70
PharmaCompass offers a list of Dapiglutide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Dapiglutide manufacturer or Dapiglutide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dapiglutide manufacturer or Dapiglutide supplier.
A AT42617 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AT42617, including repackagers and relabelers. The FDA regulates AT42617 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AT42617 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AT42617 supplier is an individual or a company that provides AT42617 active pharmaceutical ingredient (API) or AT42617 finished formulations upon request. The AT42617 suppliers may include AT42617 API manufacturers, exporters, distributors and traders.
AT42617 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AT42617 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right AT42617 GMP manufacturer or AT42617 GMP API supplier for your needs.
A AT42617 CoA (Certificate of Analysis) is a formal document that attests to AT42617's compliance with AT42617 specifications and serves as a tool for batch-level quality control.
AT42617 CoA mostly includes findings from lab analyses of a specific batch. For each AT42617 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AT42617 may be tested according to a variety of international standards, such as European Pharmacopoeia (AT42617 EP), AT42617 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AT42617 USP).
